DarioHealth Corp. 8-K Report: Future Insights for Investors (Dec 16, 2024)

Based on the provided XML section of a financial report, here are the key details extracted:

1. Company Information:

• Name: DarioHealth Corp.
• CIK: 0001533998
• SEC Filing Type: 8-K
• NASDAQ Ticker: DRIO
• Address: 322 W 57th St #33B, New York, NY 10019
• Phone Number: 972-4-770-6377

2. Filing Date:

• The report is dated December 16, 2024.

3. Identifiers:

• Entity Identifier: The identifier scheme is linked to the SEC's Central Index Key (CIK).
• Entity's IRS Employer Identification Number (EIN): 45-2973162.

4. Stock Information:

• Common Stock Par Value: $0.0001 per share.
• Units of Measure: The financial data is reported in USD and shares.

5. Reporting Context:

• The context refers to a specific date for the financial data, which is both the start and end date of the reporting period (December 16, 2024).

6. Measurement Units:

• The report uses USD as the currency for financial measures and shares for stock-related measurements.

Insights:

• The filing date being in the future (December 16, 2024) suggests this may be a projection or a planned event rather than a historical report.
• The par value of the common stock is very low, which might indicate that the company is in a growth phase or has a strategy focused on expansion and investment rather than high initial capital returns to shareholders.
• The 8-K filing type suggests that this report may contain important news or events that shareholders should be aware of, which could affect the company's stock performance or operations.
• The inclusion of the CIK and EIN indicates compliance with SEC reporting requirements, reinforcing transparency in corporate governance.

This information could be useful for analysts looking to understand DarioHealth's current standing, compliance, and market positioning as of the specified date.